Trendy Stocks
What Was The Reason Behind Dear Cashmere (DRCR) Stock Increasing 13% Last Session?
Dear Cashmere Holding Co (OTC: DRCR) stock closed up 13.04% to $0.2600 in the past session for its app being accepted in Europe. The Dear
Day: May 9, 2022
Equity Investing
What Drove Nitches (NICH) Stock Up 27% On Friday?
Nitches Inc (OTC: NICH) stock closed up 27.27% to $0.0560 in the past session after the company announced the completion of a significant filing. The
Trendy Stocks
What Led The Nova Mentis (NMLSF) Stock To Increase 15% On Friday?
Nova Mentis Life Science Corp (NMLSF) closed up 15.25 percent on Friday at $0.0747 as the company advances its drug development program. Shares of Nova
Equity Investing
What Drove The NuGene (NUGN) Stock Up 25% During Last Trading?
NuGene International Inc [NUGN] stock was booming at the previous close as it surged 24.62% to $0.1058 after announcing its office expansion plan. NuGene (NUGN)
Trendy Stocks
What Happened On Friday To Make Marijuana Strategic Ventures (MSVI) Stock Jump 24%?
Marijuana Strategic Ventures Inc (OTC-MSVI) stock surged significantly as it recorded rise of 23.97% to $0.0750 at previous close after the company signed a disaster
Trendy Stocks
What Drove The Cytta (CYCA) Stock Higher In Friday Trades?
Cytta Corp (CYCA) closed the last session at $0.2800 after seeing a rise of 20.69% after featuring its video integration technology. The rise brought the
Market Insights
What Motivated Columbia Care (CCHWF) Stock To Climb 14%?
Columbia Care Inc (OTC:CCHWF) surged up 13.90 percent to $2.1300 at Friday’s close following the introduction of new flower brands. The volume of Columbia Care
Featured
What Caused The Sibannac (SNNC) Stock To Rise 28% Last Session?
Sibannac Inc (OTC: SNNC) surged up 28.26% to $0.0590 at the previous close after announcing a significant new collaboration. The volume of Sibannac (SNNC) stock
Equity Investing
What Caused The RegeneRx (RGRX) Stock To Rise On Friday?
RegeneRx Biopharmaceuticals Inc (RGRX) closed up 28.62 percent on Friday at $0.2000 after its lead product finds to be showing progressive therapeutic efficacy. RegeneRx (RGRX)
